Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Hydroxy-delta-5-steroid dehydrogenase, 3 beta, pseudogene 1 (HSD3BP1) is classified as a pseudogene closely related to the functional HSD3B1 and HSD3B2 genes, which encode steroidogenic enzymes critical for the biosynthesis of progesterone, androgens, estrogens, and other steroid hormones. HSD3BP1 itself does not encode an active enzyme or protein product and is not known to participate in biological processes, disease, or serve as a therapeutic target. Most literature and pharmacological resources focus on the protein-coding genes HSD3B1 and HSD3B2, not the pseudogene HSD3BP1. Functional roles related to steroid hormone biosynthesis, disease, and drug interactions are described only for HSD3B1/HSD3B2 (protein-coding genes), not for HSD3BP1 (pseudogene).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hydroxy-delta-5-steroid dehydrogenase, 3 beta, pseudogene 1 (HSD3BP1).